Spok Holdings, Inc. (NASDAQ: SPOK) Stock Competitors & Peer Comparison

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, GEHC has a market cap of 32.6B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while GEHC trades at $72.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas GEHC's P/E ratio is 15.85. In terms of profitability, SPOK's ROE is +0.09%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SPOK is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check GEHC's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SPOK is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check GEHCV's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, BTSG has a market cap of 11.7B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while BTSG trades at $59.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas BTSG's P/E ratio is 48.13. In terms of profitability, SPOK's ROE is +0.09%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, SPOK is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BTSG's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, TEM has a market cap of 9.6B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while TEM trades at $54.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas TEM's P/E ratio is -109.22. In terms of profitability, SPOK's ROE is +0.09%, compared to TEM's ROE of -0.55%. Regarding short-term risk, SPOK is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check TEM's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SPOK's ROE is +0.09%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SPOK is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SGFY's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while HQY trades at $105.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas HQY's P/E ratio is 24.65. In terms of profitability, SPOK's ROE is +0.09%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SPOK is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HQY's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, TXG has a market cap of 7.3B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while TXG trades at $57.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas TXG's P/E ratio is -339.71. In terms of profitability, SPOK's ROE is +0.09%, compared to TXG's ROE of -0.09%. Regarding short-term risk, SPOK is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check TXG's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while HNGE trades at $86.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas HNGE's P/E ratio is 46.19. In terms of profitability, SPOK's ROE is +0.09%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, SPOK is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HNGE's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas RCM's P/E ratio is -102.21. In terms of profitability, SPOK's ROE is +0.09%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SPOK is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check RCM's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, WAY has a market cap of 4.7B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while WAY trades at $24.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas WAY's P/E ratio is 16.25. In terms of profitability, SPOK's ROE is +0.09%, compared to WAY's ROE of +0.04%. Regarding short-term risk, SPOK is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check WAY's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, DOCS has a market cap of 4.7B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while DOCS trades at $24.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas DOCS's P/E ratio is 16.33. In terms of profitability, SPOK's ROE is +0.09%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, SPOK is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check DOCS's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SPOK's ROE is +0.09%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SPOK is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check ONEM's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while PRVA trades at $21.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas PRVA's P/E ratio is 102.57. In terms of profitability, SPOK's ROE is +0.09%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, SPOK is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check PRVA's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, HTFL has a market cap of 2.6B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while HTFL trades at $29.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas HTFL's P/E ratio is -14.85. In terms of profitability, SPOK's ROE is +0.09%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SPOK is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HTFL's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, WGS has a market cap of 2.5B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while WGS trades at $82.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas WGS's P/E ratio is 228.86. In terms of profitability, SPOK's ROE is +0.09%, compared to WGS's ROE of -0.39%. Regarding short-term risk, SPOK is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check WGS's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while PGNY trades at $25.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas PGNY's P/E ratio is 18.42. In terms of profitability, SPOK's ROE is +0.09%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, SPOK is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check PGNY's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SPOK's ROE is +0.09%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SPOK is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check NXGN's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while OMDA trades at $23.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas OMDA's P/E ratio is 340.57. In terms of profitability, SPOK's ROE is +0.09%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, SPOK is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check OMDA's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SPOK's ROE is +0.09%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SPOK is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AGTI's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CERT trades at $8.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CERT's P/E ratio is 20.02. In terms of profitability, SPOK's ROE is +0.09%, compared to CERT's ROE of -0.07%. Regarding short-term risk, SPOK is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CERT's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while GDRX trades at $3.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas GDRX's P/E ratio is 11.22. In terms of profitability, SPOK's ROE is +0.09%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SPOK is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check GDRX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while TDOC trades at $6.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas TDOC's P/E ratio is -7.44. In terms of profitability, SPOK's ROE is +0.09%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, SPOK is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check TDOC's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SPOK is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CCLDO's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, HSTM has a market cap of 828.5M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while HSTM trades at $28.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas HSTM's P/E ratio is 35.01. In terms of profitability, SPOK's ROE is +0.09%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SPOK is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check HSTM's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, PHR has a market cap of 757.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while PHR trades at $12.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas PHR's P/E ratio is 43.79. In terms of profitability, SPOK's ROE is +0.09%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SPOK is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check PHR's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SOPH has a market cap of 635.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SOPH trades at $7.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SOPH's P/E ratio is -6.82. In terms of profitability, SPOK's ROE is +0.09%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, SPOK is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SOPH's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, SPOK is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MPLN-WT's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CTEV has a market cap of 596M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CTEV trades at $35.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CTEV's P/E ratio is -2.06. In terms of profitability, SPOK's ROE is +0.09%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, SPOK is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CTEV's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SPOK's ROE is +0.09%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SPOK is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check ACCD's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SPOK's ROE is +0.09%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SPOK is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SHCR's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, EVH has a market cap of 469.6M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while EVH trades at $4.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas EVH's P/E ratio is 32.12. In terms of profitability, SPOK's ROE is +0.09%, compared to EVH's ROE of -0.99%. Regarding short-term risk, SPOK is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check EVH's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, NRC has a market cap of 464.5M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while NRC trades at $20.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas NRC's P/E ratio is 25.13. In terms of profitability, SPOK's ROE is +0.09%, compared to NRC's ROE of +0.48%. Regarding short-term risk, SPOK is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check NRC's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SPOK's ROE is +0.09%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SPOK is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SLGCW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SPOK's ROE is +0.09%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SPOK is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SLGC's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SPOK's ROE is +0.09%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SPOK is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check TBRG's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SPOK's ROE is +0.09%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, SPOK is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MPLN's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SY has a market cap of 295.2M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SY trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SY's P/E ratio is -6.82. In terms of profitability, SPOK's ROE is +0.09%, compared to SY's ROE of -0.16%. Regarding short-term risk, SPOK is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SY's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SPOK's ROE is +0.09%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SPOK is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check TRHC's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SMFR's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SMFR's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, AMWL has a market cap of 214.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while AMWL trades at $12.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas AMWL's P/E ratio is -2.86. In terms of profitability, SPOK's ROE is +0.09%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, SPOK is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check AMWL's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SPOK's ROE is +0.09%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SPOK is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CPSI's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, HCAT has a market cap of 132.3M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while HCAT trades at $1.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas HCAT's P/E ratio is 8.95. In terms of profitability, SPOK's ROE is +0.09%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, SPOK is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HCAT's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, OPRX has a market cap of 132.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while OPRX trades at $7.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas OPRX's P/E ratio is 6.46. In terms of profitability, SPOK's ROE is +0.09%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SPOK is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check OPRX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SPOK's ROE is +0.09%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SPOK is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AUGX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CCLD trades at $2.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CCLD's P/E ratio is 9.42. In terms of profitability, SPOK's ROE is +0.09%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SPOK is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check CCLD's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while WORX trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas WORX's P/E ratio is -6.40. In terms of profitability, SPOK's ROE is +0.09%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SPOK is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check WORX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, DH has a market cap of 68.6M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while DH trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas DH's P/E ratio is 2.50. In terms of profitability, SPOK's ROE is +0.09%, compared to DH's ROE of -0.75%. Regarding short-term risk, SPOK is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check DH's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas FORA's P/E ratio is -24.11. In terms of profitability, SPOK's ROE is +0.09%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SPOK is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check FORA's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SPOK is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CCLDP's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ONMD has a market cap of 42.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ONMD trades at $0.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ONMD's P/E ratio is -4.92. In terms of profitability, SPOK's ROE is +0.09%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SPOK is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ONMD's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SPOK's ROE is +0.09%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SPOK is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SNCE's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SPOK's ROE is +0.09%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SPOK is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AKLI's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SPOK's ROE is +0.09%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SPOK is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check SHLT's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.09%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SPOK is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SHCRW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ONMDW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SPOK is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ONMDW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas STRM's P/E ratio is -2.40. In terms of profitability, SPOK's ROE is +0.09%, compared to STRM's ROE of -0.65%. Regarding short-term risk, SPOK is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check STRM's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SPOK's ROE is +0.09%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SPOK is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check RNLX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SPOK's ROE is +0.09%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SPOK is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check LIFW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SCNX has a market cap of 17.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SCNX trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SCNX's P/E ratio is -0.17. In terms of profitability, SPOK's ROE is +0.09%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SPOK is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SCNX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SPOK's ROE is +0.09%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SPOK is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BBLN's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, BEATW has a market cap of 13M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while BEATW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas BEATW's P/E ratio is -0.03. In terms of profitability, SPOK's ROE is +0.09%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SPOK is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BEATW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while BFRG trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas BFRG's P/E ratio is -1.07. In terms of profitability, SPOK's ROE is +0.09%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SPOK is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check BFRG's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SPOK's ROE is +0.09%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SPOK is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ETAO's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MGRX trades at $0.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MGRX's P/E ratio is -0.39. In terms of profitability, SPOK's ROE is +0.09%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SPOK is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MGRX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SPOK is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check UPH-WT's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas UPH's P/E ratio is -0.07. In terms of profitability, SPOK's ROE is +0.09%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SPOK is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check UPH's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SPOK's ROE is +0.09%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check PEAR's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.09%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check PEARW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SPOK's ROE is +0.09%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SPOK is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check OTRK's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.09%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SPOK is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CMAX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, HCTI has a market cap of 1.4M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while HCTI trades at $1.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas HCTI's P/E ratio is -0.16. In terms of profitability, SPOK's ROE is +0.09%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SPOK is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check HCTI's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SPOK's ROE is +0.09%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SPOK is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check VSEEW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SPOK is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check LIFWZ's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ACON trades at $2.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ACON's P/E ratio is -0.25. In terms of profitability, SPOK's ROE is +0.09%, compared to ACON's ROE of -0.59%. Regarding short-term risk, SPOK is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ACON's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while EUDAW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, SPOK's ROE is +0.09%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, SPOK is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check EUDAW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while VSEE trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas VSEE's P/E ratio is -0.10. In terms of profitability, SPOK's ROE is +0.09%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SPOK is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check VSEE's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SPOK is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MSPRZ's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.09%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, SPOK is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check KERNW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas KERN's P/E ratio is -0.01. In terms of profitability, SPOK's ROE is +0.09%, compared to KERN's ROE of -0.20%. Regarding short-term risk, SPOK is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check KERN's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SPOK is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check LIFWW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ZCMD has a market cap of 37.2K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ZCMD trades at $1.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, SPOK's ROE is +0.09%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SPOK is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check ZCMD's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SPOK is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CMAXW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, ACONW has a market cap of 13.1K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while ACONW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas ACONW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, SPOK is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check ACONW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, SPOK's ROE is +0.09%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, SPOK is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check WGSWW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas AFFX's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SPOK is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check AFFX's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SPOK is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CHNGU's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SPOK's ROE is +0.09%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SPOK is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CSLT's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, NH has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas NH's P/E ratio is -0.12. In terms of profitability, SPOK's ROE is +0.09%, compared to NH's ROE of +0.35%. Regarding short-term risk, SPOK is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check NH's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SPOK is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check MTBCP's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CERN's P/E ratio is 55.84. In terms of profitability, SPOK's ROE is +0.09%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SPOK is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CERN's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SPOK is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check MTBCO's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SPOK's ROE is +0.09%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SPOK is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CHNG's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SPOK's ROE is +0.09%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SPOK is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check CNVY's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MTBC's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, SPOK is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MTBC's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas KURIU's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, SPOK is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check KURIU's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SPOK is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check MSPRV's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas NAVA's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, SPOK is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for SPOK.Check NAVA's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, SPOK is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for SPOK.Check SMFRW's competition here

Spok Holdings, Inc. (NASDAQ: SPOK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SPOK stands at 229.3M. In comparison, IMS has a market cap of 0. Regarding current trading prices, SPOK is priced at $10.98 on the NASDAQ, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SPOK currently has a P/E ratio of 18.30, whereas IMS's P/E ratio is N/A. In terms of profitability, SPOK's ROE is +0.09%, compared to IMS's ROE of +0.27%. Regarding short-term risk, SPOK is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for SPOK.Check IMS's competition here